Calcium and Phosphate regulation Flashcards
State some roles of calcium in the body.
- Control of neuromuscular excitability
- Muscle Contraction
- Strength in bone; calcium reservoir in bone
- Blood clotting
- Intracellular second messenger/co-enzyme
Where and how is calcium mainly stored? What are the other sites?
99% of calcium in the body is stored in bone in the form of complex hydrated calcium phosphate salts called hydroxyapatite crystals.
Found in all cells (low in cytoplasm and relatively high in specialised organelles), + blood and other extracellular fluids.
How is calcium present in the blood, and in what proportions? Which is the bio-active component?
Unbound ionised calcium (Ca2+) = 1.25mM = 50%
Bound to plasma proteins = 1.15mM = 45%
Tiny bit as soluble salts
What is the usual daily intake of calcium? Briefly describe how this calcium is absorbed into the blood from the gut.
1000 mg/day
- Trans-cellular transport (mainly) in the duodenum involving specific binding proteins.
- Passive para-cellular transport throughout small intestine (especially when calcium intake is high)
State the main organs involved in the fine regulation of plasma calcium, and what other tissue is also involved
Kidneys
and bone
Where, and in what proportions, is calcium reabsorbed in the nephron?
- PCT = 70%
Principal component which is regulated:
- Ascending limb of LoH = 20%
- DCT
What two hormones raise plasma calcium concentration?
Parathyroid Hormone (PTH) Calcitriol (1,25-dihydroxycholecalciferol)
State and describe the two receptors of PTH
PTHR1 and PTHR2
GPCRs
Activation => increased adenyl cyclase activity => increased synthesis of cAMP => activation of PKA pathway
Found particularly in bone and kidneys
Where is PTH synthesised/stored?
PTH is synthesised and stored in chief cells of the parathyroid glands (two superior and two inferior glands located at the back of the thyroid)
Describe the effect of PTH on bone to explain its role in raising plasma calcium (and hence phosphate) concentration
- PTH binds to PTHR1 receptors on osteoblasts
- Stimulates their release of osteoclast-activating factors (which include the cytokines RANKL and M-CSF)
- Once activated, osteoclasts release acids and proteolytic enzymes into the nearby osteoid => bone resorption = release of Ca2+ (and phosphate) into ECF and blood
- PTH (when bound) also decreases synthesis of osteoprotegerin by osteoblasts (a molecule which decreases RANKL binding to its receptor reducing osteoclast formation and activation)
- Note that PTH also promotes osteoclast/osteoblast development form precursors
Describe the effect of PTH on the kidneys (concerning calcium and phosphate reabsorption)
Acting through its PTHR1 receptor, PTH:
- Stimulates calcium reabsorption; 65% PCT, 20% thick limb of LoH, 15% DCT
- Promotes phosphate ion excretion (and sodium ion excretion) via down-regulation of sodium-phosphate co-transporters.
Why is the PTH-induced excretion of phosphate by the kidneys important?
- Overall, considering the effects of PTH on bone and the kidneys, plasma calcium concentration is increased but the plasma phosphate concentration is maintained.
- Therefore, the likelihood that calcium phosphate salts will be deposited in the soft tissues decreases, since the dissociation constant is maintained (between the ions and their salt)
Describe the effect of PTH on the kidneys (concerning calcitriol synthesis)
- PTH acts on endocrine cells (via PTHR1) found between the cells of the PCT.
- Stimulates calcitriol synthesis by acting as a transcription factor for the 1α-hydroxylase enzyme.
Describe the control of the synthesis and release of PTH (stimulating and inhibiting factors)
- Chief cells respond to changes in circulating Ca2+ by means of a calcium-sensing receptor (CaR) on its cell membrane.
CaR = GPCR that, when activated by ligand (Ca2+) binding, inhibits the adenyl cyclase-cAMP pathway and stimulates the PLC-IP3, DAG pathway. - Therefore, a fall in plasma calcium concentration => reduction in ligand binding => decreased activation of the PLC pathway => decreased release of Ca2+ from intracellular stores => decreased inhibition of PTH release.
ALSO;
- Catecholamines (by binding to beta receptors)
What type of molecule is calcitriol? What is it derived form?
Steroid hormone
Bioactive derivative/metabolite of vitamin D3 (cholecalciferol)
What are the ways in which vitamin D3 may be obtained?
- Ingested in the diet
- Synthesised in the skin (epidermis and dermis layers) from its early precursor 7-dehydrocholesterol; UVB light brings about the conversion
Note: ergocalciferol (vitamin D2) found in certain algae/fungi may also be utilised.
Describe the synthesis and transport of calcitriol
- Cholecalciferol once synthesised is transported in the circulation mainly (85%) bound to cholecalciferol- binding protein, CBP / vitamin D–binding protein, VDBP; also albumin (with less than 0.5% free/bioactive)
- It reaches the liver where it gets rapidly hydroxylated in various positions, the main hydroxylation being catalysed by a 25-hydroxylase enzyme, forming 25-hydroxycholecalciferol (25 OH-D3).
- 25 OH-D3 is stored in the liver which normally contains at least 3 months’ supply of it, and which accounts for the liver being a good source of vitamin D3.
- The 25 OH-D3 (from the circulation) is then 1α-hydroxylated in various tissues, but mainly in epithelial cells of the renal PCTs.
- The 1α-hydroxylase activity is the determining factor for the production of calcitriol (aka 1,25 (OH)2 cholecalciferol)
Why is calcitriol not stored to any significant extent in the cells where it is produced?
(Like its precursors), it is a steroid hormone and hence it is lipophilic.
Therefore it is only synthesised when the proximal tubular cells are appropriately stimulated
State the half life of calcitriol
Between 3 and 6 hours
Describe the general receptor-mediated mechanism of action of calcitriol
- Calcitriol binds to specific intracellular receptors (vitamin D3 receptors, VDR) which also bind related ligands such as the 25 OH-D3 metabolite.
- These receptors are part of the retinoic acid family of receptors.
- Once bound to its receptor, it acts as a transcription factor modulating gene activity => new protein synthesis, but it does so only after forming a complex with the retinoid X receptor.